Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

(2010) Douglas B. Evans et al.   ANNALS OF SURGICAL ONCOLOGY

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

(2010) Yun Shin Chun et al.   ANNALS OF SURGICAL ONCOLOGY

Progress for resectable cancer?

(2010) Jessica P. Simons et al.   CANCER

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

(2010) Jerome Landry et al.   JOURNAL OF SURGICAL ONCOLOGY

Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Ross A. Abrams et al.   ANNALS OF SURGICAL ONCOLOGY

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

(2009) Mark P. Callery et al.   ANNALS OF SURGICAL ONCOLOGY

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma

(2008) Kimberly M. Brown et al.   AMERICAN JOURNAL OF SURGERY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS